Protocol No.: EA4151

Title
A Randomized Phase III Trial of Consolidation with Autologous Hematopoietic Cell Transplantation Followed by Maintenance Rituximab vs. Maintenance Rituximab Alone for Patients with Mantle Cell Lymphoma In Minimal Residual Disease-Negative First Complete Remission
Principal Investigator
Veltri, Lauren
Phase
III
Age Group
Adult
Applicable Disease Site
Lymphoma
Participating Institutions
Camden Clark Medical Center
Mary Babb Randolph Cancer Center
Contacts
Kristin Volk, RN
Research Nurse
Phone: +1 304-581-1893
Layla Tannoury
Clinical Research Specialist
Phone: +1 304-424-2585

View on ClinicalTrials.gov